Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

4.64
+0.05001.09%
Post-market: 4.640.00000.00%18:08 EST
Volume:1.36M
Turnover:6.28M
Market Cap:892.38M
PE:-20.66
High:4.69
Open:4.62
Low:4.54
Close:4.59
52wk High:5.10
52wk Low:2.71
Shares:192.32M
Float Shares:126.05M
Volume Ratio:0.85
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2246
EPS(LYR):-0.3767
ROE:-45.88%
ROA:-16.46%
PB:11.53
PE(LYR):-12.32

Loading ...

Mar 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 11, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report